Floatz logo

108 assets in Idiopathic Pulmonary Fibrosis

Therapeutic assets addressing Idiopathic Pulmonary Fibrosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Abbv-142
Idiopathic Pulmonary Fibrosis
AbbVieP2CCC (51)
ak3280
Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd.P2CCC (51)
bi 1839100
Idiopathic Pulmonary Fibrosis
Boehringer IngelheimP2CCC (51)
bi 765423
Idiopathic Pulmonary Fibrosis
Boehringer IngelheimP2CCC (51)
cal101
Idiopathic Pulmonary Fibrosis
Calluna Pharma ASP2CCC (51)
Cudetaxestat
Idiopathic Pulmonary Fibrosis
Blade TherapeuticsP2CCC (51)
Env-101
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc.P2CCC (51)
Fipaxalparant
Idiopathic Pulmonary Fibrosis
AmgenP2CCC (51)
Hymecromone
Idiopathic Pulmonary Fibrosis
National Institute of Environmental Health Sciences (NIEHS)P2CCC (51)
Ifetroban
Idiopathic Pulmonary Fibrosis
Cumberland PharmaceuticalsP2CCC (51)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer
Idiopathic Pulmonary Fibrosis
Syndax PharmaceuticalsP2CCC (51)
Leramistat
Idiopathic Pulmonary Fibrosis
Modern Biosciences LtdP2CCC (51)
ltp001
Idiopathic Pulmonary Fibrosis
Novartis PharmaceuticalsP2CCC (51)
Mtx-463
Idiopathic Pulmonary Fibrosis
Mediar TherapeuticsP2CCC (51)
Nicotinamide Ribonucleoside
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical CenterP2CCC (51)
Senicapoc
Idiopathic Pulmonary Fibrosis
Vejle HospitalP2CCC (51)
Suplatast Tosylate
Idiopathic Pulmonary Fibrosis
Melius Pharma ABP2CCC (51)
Vixarelimab
Idiopathic Pulmonary Fibrosis
Genentech, Inc.P2CCC (51)
Zinc
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical CenterP2CCC (51)
Agmb-447
Idiopathic Pulmonary Fibrosis
Agomab Spain S.L.P1CC (47)
Aro-Mmp7 Inhalation
Idiopathic Pulmonary Fibrosis
Arrowhead PharmaceuticalsP1/2CC (46)
Saracatinib
Idiopathic Pulmonary Fibrosis
National Jewish HealthP1/2CC (45)
Orvepitant
Idiopathic Pulmonary Fibrosis
Nerre Therapeutics Ltd.P2CC (44)
Alemtuzumab
Idiopathic Pulmonary Fibrosis
Paul SzabolcsP1/2CC (43)
Car-Dc
Idiopathic Pulmonary Fibrosis
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
cd3/cd19 negative allogeneic hematopoietic stem cells
Idiopathic Pulmonary Fibrosis
Paul SzabolcsP1/2CC (43)
Fludarabine
Idiopathic Pulmonary Fibrosis
Paul SzabolcsP1/2CC (43)
Hydroxyurea
Idiopathic Pulmonary Fibrosis
Paul SzabolcsP1/2CC (43)
Lung Spheroid Stem Cells 200 Million
Idiopathic Pulmonary Fibrosis
University of North Carolina, Chapel HillP1CC (43)
Thiotepa
Idiopathic Pulmonary Fibrosis
Paul SzabolcsP1/2CC (43)
AZ-14226229
Idiopathic Pulmonary Fibrosis
AstraZenecaP1CC (42)
c106
Idiopathic Pulmonary Fibrosis
Vicore Pharma ABP1CC (42)
chf10067 high dose --
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A.P1CC (42)
Excl-100,
Idiopathic Pulmonary Fibrosis
Excalibur Pharmaceuticals, Inc.P1CC (42)
hul001
Idiopathic Pulmonary Fibrosis
HuniLife Biotechnology, Inc.P1CC (42)
Human Umbilical Cord Mesenchymal Stem Cell
Idiopathic Pulmonary Fibrosis
Shanghai Life Science & TechnologyP1CC (42)
Srn-001
Idiopathic Pulmonary Fibrosis
siRNAgen Therapeutics Inc.P1CC (42)
Ang-3070
Idiopathic Pulmonary Fibrosis
Angion Biomedica CorpP1CC (41)
9mw3811
Idiopathic Pulmonary Fibrosis
Mabwell (Shanghai) Bioscience Co., Ltd.P1C (39)
AIR
Idiopathic Pulmonary Fibrosis
Dr. Denis O'DonnellEarly P1C (39)
Allorx
Idiopathic Pulmonary Fibrosis
The Foundation for Orthopaedics and Regenerative MedicineP1C (39)
Artesunate
Idiopathic Pulmonary Fibrosis
Joseph C. WuP1C (39)
Atezolizumab
Idiopathic Pulmonary Fibrosis
Cedars-Sinai Medical CenterP1C (39)
Dpa-714
Idiopathic Pulmonary Fibrosis
University of Alabama at BirminghamP1C (39)
Fludeoxyglucose
Idiopathic Pulmonary Fibrosis
University of Alabama at BirminghamP1C (39)
Gns-3545
Idiopathic Pulmonary Fibrosis
Genosco Inc.P1C (39)
rsn0402 part 1
Idiopathic Pulmonary Fibrosis
Shenzhen Resproly Biopharmaceutical Co., LtdP1C (39)
Venetoclax
Idiopathic Pulmonary Fibrosis
University of Alabama at BirminghamEarly P1C (39)
vum02
Idiopathic Pulmonary Fibrosis
Wuhan Optics Valley Vcanbiopharma Co., Ltd.P1C (39)
Azithromycin
Idiopathic Pulmonary Fibrosis
Assiut UniversityN/AD (30)
Showing 51 to 100 of 108 assets
PreviousPage 2 of 3Next